Close
Absci and Owkin have formed a strategic partnership to merge their AI platforms, aiming to expedite the discovery and design of innovative therapeutics. This collaboration focuses on developing therapeutic candidates that target novel areas in immuno-oncology and other medical indications. By leveraging their combined expertise, both companies seek to enhance the efficiency of drug development processes.
The partnership signifies a significant step forward in the application of AI in healthcare, particularly in the realm of drug discovery. By integrating their technologies, Absci and Owkin can potentially unlock new therapeutic avenues that were previously unexplored. This collaboration not only highlights the growing importance of AI in medicine but also sets a precedent for future partnerships in the industry.
• Absci and Owkin combine AI platforms for therapeutic discovery.
• Partnership focuses on immuno-oncology and novel therapeutic targets.
AI platforms are integrated systems that utilize artificial intelligence to enhance drug discovery processes.
Therapeutic candidates refer to potential drug compounds developed for treating specific medical conditions.
Immuno-oncology is a field of medicine that focuses on harnessing the immune system to fight cancer.
Absci specializes in AI-driven drug discovery, aiming to streamline the development of new therapeutics.
Owkin utilizes AI to analyze medical data, enhancing the identification of novel therapeutic targets.
FierceBiotech 14month
YAHOO!Finance 7month
Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600
How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.
Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.
Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.
Log in
Sign Up
AI Tools - Popular
AI Tools - Categories
GPTs - Categories
AI for Jobs
Key AI Highlights in this Article
Key AI Terms Mentioned in this Article
Companies Mentioned in this Article
